Green EnviroTech Holdings Corp. (PINK: GETH) reached up 56.52% in morning trading to $.036 with 1M shares traded. Green EnviroTech Holdings Corp. is a plastics and tires recovery and recycling company which removes contaminants from recovered plastic recaptured from end of life automotive vehicles shredded for their metal. Green EnviroTech Holdings Corp. processes this recovered plastic to produce compounded plastic resin and light sweet crude oil as end products. Its unique patented process significantly reduces the amount of shredder residue going to landfills by up to 40 percent creating considerable cost savings for metal recyclers while also dramatically reducing the volume of materials going to the landfill. Green EnviroTech Holdings Corp. (Pinksheets: GETH.PK - News) announced Friday they have sold the "permit to construct" for the Riverbank, California proposed waste plastic to oil processing facility to WM Riverbank Recovery , LLC, Beaverton, OR.
iBrands Corp. (PINK: IBRC) reached up 50% in morning trading to $.0003 with 70M shares traded. iBrands Corp. is a publicly traded holding company that acquires and operates niche market brands having unique market positioning with substantial upside. Their strategy is executed through the acquisition of proprietary brands having unique market niches with substantial upside growth and providing strong management. A common thread throughout their acquisitions is the application of Internet technology to enhance revenues and optimize margins. iBrands Corp. (OTC: IBRC.PK - News) announced it has received a Conditional Commitment Letter from an undisclosed investment group intending to provide the company with $10 million USD. This funding is for the completion of the company's acquisitions, software enhances for iMenu24/7 and working capital. According to the company, all of the terms and fees of the financing have been agreed upon. The company expects to receive the first tranche of funding in the next 90-days.
A.P. Pharma, Inc. (OTCBB: APPA) reached up 10.77% in morning trading to $.36 with 150K shares traded. A.P. Pharma is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery technology. The Company's primary focus is on its lead product, APF530, for the prevention of CINV. A.P. Pharma received a Complete Response Letter on the APF530 NDA and is targeting the resubmission of the NDA for mid-2012. The Company has additional research and development programs that utilize its bioerodible, injectable and implantable delivery systems. A.P. Pharma, Inc. (OTC.BB: APPA) announced results of its thorough QT (tQT) study of APF530, its lead product candidate being developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV). The study was conducted to assess the potential for granisetron, the active drug in APF530, to prolong the QT interval across a wide range of plasma drug concentrations. The study met its protocol-specified primary end point and demonstrated that granisetron did not have an effect on cardiac repolarization as measured by prolongation of the QT interval. A pharmacokinetic/pharmacodynamic (PK/PD) analysis demonstrated that there was no relationship between plasma granisetron concentrations and the heart-rate-corrected QT interval (QTc) (slope of zero).
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
